Description
Regular Monthly Meeting.
Cambridge Biosafety Committee Meeting Agenda 2-21-19
Link to Agenda (PDF)
Introductions
Presentations
EdiGENE (Tetsuya Yamagata) will present a request for a new BSL-2 ONLY permit for their facility at 51 Moulton Street.
Werewolf Therapeutics (Heather Brodkin, Dan Hicklin) will present a request for a new BSL-2 ONLY permit for their facility at 1030 Massachusetts Ave., Suite 210.
Kronos Bio (David Freeman, Marius Pop) will present a request for a new BSL-2 ONLY permit for their facility within Mass Innovation Labs at 21 Erie Street.
Ibsen BioLabs (Laura Brandano) will present a require for a new BSL-2 ONLY permit for their incubator facility at 650 East Kendall Street, 2nd Floor.
Old Business/Site visits
2/8/19 – Surface Oncology (50 Hampshire Street, 8th Floor) Street) amendment walkthrough for conversion to BSL-2 ONLY (converting all BSL-1 lab areas to BSL-2). BPHC participation
2/11/19 – Bristol-Myers Squibb (100 Binney Street, 3rd and 4th Floors) walkthrough for new BSL-2 ONLY permit
2/20/19 – Celsius Therapeutics (399 Binney Street) walkthrough for relocation to new location
2/20/19 – Relay Therapeutics (399 Binney Street) walkthrough for relocation to new location
New Business
Adjourn